SEASONAL VACCINATIONS
FLU SHOT, COVID-19 & RSV UPDATES
Vaccination Updates
Wednesday April 29, 2026 4:12PM
This page will be updated regularly to display current inventory
-
Regular flu shots 6months – 64 years LOW STOCK
Regular 65+ flu shots LOW STOCK
High dose 65+ flu shots OUT OF STOCK
-
For KMC patients and general public (12+ years of age) to book.
UNAVAILABLE until next covid booster becomes available spring or Fall 2026
Covid Vaccine: PFIZER
-
***RSV is publicly funded to all individuals aged 75 and older***
75+ AREXVY® Vaccine: Available now, LOW STOCK
BOOK HEREHIGH RISK 60-74, AREXVY® Vaccine: LOW STOCK
BOOK HERE
Eligibility Criteria:lives in long term care/retirement residences
on hemo/ or peritoneal dialysis
patient with glomerulonephritis (GN) and is moderately-severely immunocompromised
organ/stem cell transplant recipients
patients experiencing homelessness
identify as First Nations, Inuit, or Metis
-
Beyfortus (weight 5kg+) IN STOCK
BOOK HEREBeyfortus (weight under 5kg) Limited doses LOW STOCK
BOOK HEREBeyfortus® is publicly funded for administration in infants in the following groups:
Infants born before the RSV season (born on or after April 1, 2025 and younger than 8 months of age at time of administration).
Infants born during the season who did NOT receive Beyfortus in hospital.
Infants born outside of hospital settings.
Children up to 24 months of age who remain vulnerable from severe RSV disease through their second RSV season, following discussion with a health care provider, including:
chronic lung disease of prematurity (CLD), including bronchopulmonary dysplasia/chronic lung disease
hemodynamically significant congenital heart disease (CHD)
severe immunodeficiency
Down syndrome/Trisomy 21
cystic fibrosis with respiratory involvement and/or growth delay neuromuscular disease
severe congenital airway anomalies impairing the clearing of respiratory secretions
-
OUT OF STOCK
RSV Vaccine (ABRYSVO®) for PREGNANT patients 32 to 36 weeks gestational age who will deliver during the RSV season. Only one RSV product is recommended for infant protection. NACI recommends BEYFORTUS® as the preferred option over maternal vaccination in pregnancy, except in specific cases (e.g., high-risk infants born to vaccinated mothers).
BOOK HERE, or get during your next prenatal visit
RSV season has ended, check back Fall 2026